AmpliPhi Biosciences Announces M. Scott Salka as New CEO

/in

Link here. Biotechnology entrepreneur brings extensive business development and fundraising expertise to leading bacteriophage-based antibacterials company. San Diego and Richmond, VA, USA, Ljubljana, Slovenia, and Sydney, Australia, April 30, 2015 – AmpliPhi BioSciences Corporation (OTCQB: APHB), a global leader in developing bacteriophage-based antibacterial therapies to treat drug resistant infections, today announced that Scott Salka has been appointed […]

Read more

Rex Bionics CEO on rising demand for robotic legs in patient recovery

/in ,

By Nigel Roberts. April 28 2015. Link here. Crispin Simon, chief executive of Rex Bionics (LON:RXB), says the company’s robotic walking device is now attracting the attention of specialist rehabilitation clinics from around the world. ‘Now we do have distribution partners who are expert in the field of neuro-rehabilitation from all over the world who are now coming to […]

Read more

Avita Medical Granted CE Mark for Expanded ReCell™

/in

Australia, 27 April 2015. Read announcement here.

Read more

Rex Bionics plc and Deltason establish partnership to commercialise the REX Robot in Hong Kong

/in ,

22 April 2015. Link here. Rex Bionics plc, the pioneer of the REX Robot technology that enhances the mobility of wheelchair users and Deltason Medical Ltd, a distributor of rehabilitation equipment in Hong Kong and China, are pleased to announce that they have signed a distribution agreement in which Deltason will exclusively represent REX in Hong […]

Read more

Avita Medical – Chronic wound RCT scoops Innovation Prize at Skin Regeneration Symposium

/in

Cambridge, 21st April 2015 —Published results from a randomized control clinical trial that used Avita Medical’s skin regenerating device to successfully treat chronic wounds have won the lead clinician the ‘Avita Medical prize for Innovation’, the company announced today…. Read more.

Read more

Avita Medical Appoints Adam Kelliher as Chief Executive Officer

/in

ASX | News Release Avita Medical  Appoints Adam Kelliher as Chief Executive Officer Australia 14 April  201 5 — Avita Medical Ltd.  (ASX: AVH ), (OTCQX: AVMXY), a regenerative medicine  company specializing in the treatment of wounds and skin defects, today announced the appointment  of  Mr. Adam Kelliher as Chief Executive Officer. Tim Rooney, who […]

Read more

Nexvet Biopharma Appoints Dr. George Gunn as Chairman

/in ,

DUBLIN, Ireland and MELBOURNE, Australia, April 1, 2015 (GLOBE NEWSWIRE) — Link here. Veterinary biologic therapy developer Nexvet Biopharma (Nasdaq:NVET) today announced it has appointed former Division Head of Novartis Animal Health Dr. George Gunn as non-executive chairman of the Nexvet Board of Directors. The appointment is effective from 31 March 2015. Until January 2015, Dr. Gunn […]

Read more

SeaDragon Investor Update April 2015

/in ,

SEA: NZX MARKET UPDATE 1 April 2015 SeaDragon Investor Update April 2015 – Link here to attachments. The update includes: • Omega 3 refined fish oil factory takes shape; • The good oil – a word from SeaDragon Chief Executive, Ross Keeley; • Picking the best opportunities; • Omega 3s may alleviate depression; • Sustainability at the […]

Read more